Currently millions of diabetes patients all over the world have to go through the pain of testing their blood glucose level – typically several times a day. A well monitored blood glucose is crucial for avoiding the complications that can arise from diabetes. Complications that also cause major spending on the public health budget. Here are some numbers to illustrate the magnitude of the disease:

• There are between 180-230 million people with diabetes world-wide.
• The direct medical cost of diabetes in the USA (primary care and treatment of complications) was $92 billion (2002 figure – has been rising since).
• On average every diabetic uses more than 1.000 USD per year on diabetes related equipment.

The blood glucose monitors available today represent a market of approximately 8 billion EUR annually. A market that we can replace by the NI-BGM developed by RSP Systems because it is:

• Non-invasive
• Calibration free
• Hand held

In other words – a solution that will revolutionize the treatment of diabetes.

For more information on current BGM devices and cost of diabetes click here

If you would like to receive additional information about RSP Systems, please contact RSP Systems at +45 63 15 71 87.